Anavex Life Sciences (AVXL) Change in Account Payables (2018 - 2025)
Anavex Life Sciences recorded quarterly Change in Account Payables of -$1.6 million in Q4 2025, up 35.37% quarter-over-quarter from -$2.5 million in Q3 2025, and up 68.18% year-over-year from -$957297.3 in Q4 2024.
Anavex Life Sciences' Change in Account Payables history runs 8 years deep, the most recent figure standing at -$1.6 million for Q4 2025.
- In Q4 2025, Change in Account Payables rose 68.18% year-over-year to -$1.6 million; the TTM figure through Dec 2025 stood at -$1.9 million (down 801.09% YoY), while the FY2025 annual figure was -$5.4 million, down 201.38% from the prior year.
- Change in Account Payables came in at -$1.6 million for Q4 2025 at Anavex Life Sciences, up from -$2.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.1 million in Q3 2024 to a low of -$5.1 million in Q4 2024.
- A 5-year average of -$78844.7 and a median of $68500.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 6265.5% in 2021 and slumped 16766.67% in 2024, its largest moves.
- Anavex Life Sciences' Change in Account Payables stood at -$104992.0 in 2021, then soared by 1493.44% to $1.5 million in 2022, then plunged by 102.05% to -$30000.0 in 2023, then plunged by 16766.67% to -$5.1 million in 2024, then surged by 68.18% to -$1.6 million in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.6 million, -$2.5 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | -1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.61 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Sep 30, 2025 | -2.49 Mn |
| Sep 30, 2025 | -2.49 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 167,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | -5.06 Mn |
| Dec 31, 2024 | -5.06 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -164,000.00 |
| Mar 31, 2024 | -566,000.00 |
| Mar 31, 2024 | -566,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Jun 30, 2023 | -2.13 Mn |
| Jun 30, 2023 | -2.13 Mn |
| Mar 31, 2023 | 993,000.00 |
| Mar 31, 2023 | 993,000.00 |
| Dec 31, 2022 | 1.46 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 698,889.00 |
| Sep 30, 2022 | 698,889.00 |
| Jun 30, 2022 | 495,004.00 |
| Jun 30, 2022 | 495,004.00 |
| Mar 31, 2022 | -2.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Dec 31, 2021 | -104,992.00 |
| Dec 31, 2021 | -104,992.00 |
| Sep 30, 2021 | 563,347.00 |
| Sep 30, 2021 | 563,347.00 |
| Jun 30, 2021 | 518,655.00 |
| Jun 30, 2021 | 518,655.00 |
| Mar 31, 2021 | -558,896.00 |
| Mar 31, 2021 | -558,896.00 |
| Dec 31, 2020 | 227,894.00 |
| Dec 31, 2020 | 227,894.00 |
| Sep 30, 2020 | 8,850.00 |
| Sep 30, 2020 | 8,850.00 |
| Jun 30, 2020 | 330,470.00 |
| Jun 30, 2020 | 330,470.00 |
| Mar 31, 2020 | -269,432.00 |
| Mar 31, 2020 | -269,432.00 |
| Dec 31, 2019 | 395,834.00 |
| Dec 31, 2019 | 395,834.00 |
| Sep 30, 2019 | 416,736.00 |
| Sep 30, 2019 | 416,736.00 |
| Jun 30, 2019 | -2.17 Mn |
| Jun 30, 2019 | -2.17 Mn |
| Mar 31, 2019 | 1.35 Mn |
| Mar 31, 2019 | 1.35 Mn |
| Dec 31, 2018 | 1.08 Mn |
| Dec 31, 2018 | 1.08 Mn |